These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4619937)

  • 1. [Results of treatment with rifampicin in 39 patients hospitalized in our service during 1970-1971-1972].
    Maalej M; Chabbou A; Zbiba M; El Gharbi B; Halfon S; El Gharbi T; Cheniti M; El Mekki L; Djen Ayah F; Chebbi ML; Jeguirim M; Ben Salah M
    Tunis Med; 1974; 52(6):313-6. PubMed ID: 4619937
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rifampicin in the treatment of newly detected destructive pulmonary tuberculosis].
    Khomenko AG; Chukanov VI
    Probl Tuberk; 1978 Jun; (6):14-20. PubMed ID: 353801
    [No Abstract]   [Full Text] [Related]  

  • 3. [Short-term chemotherapy of pulmonary tuberculosis. Pilot study].
    Poppe de Figueiredo F; Brito AA; Laborne Valle JH; Tavares PM; Trannin PL
    Bull Int Union Tuberc; 1974; 49(1):411-7. PubMed ID: 4619561
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study on rifomycin in resumption of treatment of pulmonary tuberculosis cases with polyresistant bacilli].
    Prignot J; Gyselen A; Cosemans J; De Brabandere R; Verbist L; Simon-Pouthier F
    Acta Tuberc Pneumol Belg; 1969; 60(3):487-95. PubMed ID: 4906102
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A; Raafat H; Siddiqui GM
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary clinical observations on the use of Rifampicin in chronic cavitary pulmonary tuberculosis previously treated with and resistant to other drugs].
    Mauro G
    Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):461-6. PubMed ID: 5309059
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
    Weill G; Lévy A; Guignon JP; Lecoq H; Friess JM; Maman P
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of pleural and pulmonary tuberculosis by drug combinations including rifampicin. Early results].
    Cornudella R; Garcia-Besada JA; Castellano A
    Rev Clin Esp; 1972 Jul; 126(1):59-64. PubMed ID: 5080189
    [No Abstract]   [Full Text] [Related]  

  • 10. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new antitubercular agent: rifampicin].
    Favez G
    Schweiz Rundsch Med Prax; 1970 Feb; 59(8):296-7. PubMed ID: 4996719
    [No Abstract]   [Full Text] [Related]  

  • 12. [Late results of treatment of chronic pulmonary tuberculosis with rifampicin].
    Lachowicz E; Polaczek E; Araszkiewicz W; Kozakow H; Pszonicka A; Styszewska H; Janowiec M; Grabowska R
    Gruzlica; 1973 Jul; 41(7):781-7. PubMed ID: 4730979
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of rifampicin in venous perfusion in tuberculosis].
    Perna G; Natale F
    Clin Ter; 1979 Jul; 90(1):63-73. PubMed ID: 535329
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combination therapy with butomelide and rifampicin in experimental tuberculosis in albino mice].
    Pershin GN; Zykova TN; Kutchak SN
    Probl Tuberk; 1977 Jan; (1):64-9. PubMed ID: 834763
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 16. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
    Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of different programs of chemotherapy using rifampicin in patients with newly detected destructive pulmonary tuberculosis].
    Sodikov ES; Abrarov BA
    Probl Tuberk; 1986; (5):27-30. PubMed ID: 3526322
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifampin in the treatment of drug-resistant TB.
    Vall-Spinosa A; Lester W; Moulding T; Davidson PT; McClatchy JK
    Md State Med J; 1971 Jun; 20(6):79-80. PubMed ID: 5141742
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trial with rifampicin i.v. 300 and 600 in tuberculosis patients].
    Jungbluth H
    Prax Klin Pneumol; 1984 May; 38(5):177-81. PubMed ID: 6379634
    [No Abstract]   [Full Text] [Related]  

  • 20. [Examination of administrative dosage of cyclosporine during anti-tuberculosis chemotherapy including rifampicin].
    Matsui Y; Akagawa S; Kawashima M; Suzuki J; Masuda K; Tamura A; Nagai H; Nagayama N; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2007 Jul; 82(7):563-7. PubMed ID: 17695786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.